ATAI
Price
$5.23
Change
+$0.09 (+1.75%)
Updated
Oct 3 closing price
Capitalization
1.22B
44 days until earnings call
COUR
Price
$10.25
Change
-$0.96 (-8.56%)
Updated
Oct 3 closing price
Capitalization
1.68B
18 days until earnings call
Interact to see
Advertisement

ATAI vs COUR

Header iconATAI vs COUR Comparison
Open Charts ATAI vs COURBanner chart's image
ATAI Life Sciences
Price$5.23
Change+$0.09 (+1.75%)
Volume$4.74M
Capitalization1.22B
Coursera
Price$10.25
Change-$0.96 (-8.56%)
Volume$4.09M
Capitalization1.68B
ATAI vs COUR Comparison Chart in %
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. COUR commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and COUR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ATAI: $5.23 vs. COUR: $10.25)
Brand notoriety: ATAI and COUR are both not notable
ATAI represents the Biotechnology, while COUR is part of the Other Consumer Specialties industry
Current volume relative to the 65-day Moving Average: ATAI: 81% vs. COUR: 154%
Market capitalization -- ATAI: $1.22B vs. COUR: $1.68B
ATAI [@Biotechnology] is valued at $1.22B. COUR’s [@Other Consumer Specialties] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The market cap for tickers in the [@Other Consumer Specialties] industry ranges from $8.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B. The average market capitalization across the [@Other Consumer Specialties] industry is $1.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCOUR’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • COUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATAI and COUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 3 TA indicator(s) are bullish while COUR’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 3 bullish, 5 bearish.
  • COUR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than COUR.

Price Growth

ATAI (@Biotechnology) experienced а -0.76% price change this week, while COUR (@Other Consumer Specialties) price change was -12.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -0.90%. For the same industry, the average monthly price growth was +6.84%, and the average quarterly price growth was +33.78%.

Reported Earning Dates

ATAI is expected to report earnings on Nov 18, 2025.

COUR is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Other Consumer Specialties (-0.90% weekly)

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COUR($1.68B) has a higher market cap than ATAI($1.22B). ATAI YTD gains are higher at: 293.233 vs. COUR (20.588). COUR has higher annual earnings (EBITDA): -48.9M vs. ATAI (-115.96M). COUR has more cash in the bank: 775M vs. ATAI (95.9M). COUR has less debt than ATAI: COUR (3.1M) vs ATAI (9.22M). COUR has higher revenues than ATAI: COUR (722M) vs ATAI (2.31M).
ATAICOURATAI / COUR
Capitalization1.22B1.68B73%
EBITDA-115.96M-48.9M237%
Gain YTD293.23320.5881,424%
P/E RatioN/AN/A-
Revenue2.31M722M0%
Total Cash95.9M775M12%
Total Debt9.22M3.1M297%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICOUR
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVUDX8.590.05
+0.59%
American Century Value R6
CGRCX31.580.16
+0.51%
Invesco Comstock Select C
TNBRX20.830.04
+0.21%
1290 SmartBeta Equity R
PBCJX50.400.06
+0.12%
Principal Blue Chip J
FEXRX12.00N/A
N/A
First Eagle U.S. SMID Cap Opportunity R6

COUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COUR has been loosely correlated with UDMY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if COUR jumps, then UDMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COUR
1D Price
Change %
COUR100%
-8.56%
UDMY - COUR
54%
Loosely correlated
-1.17%
ARLO - COUR
46%
Loosely correlated
+1.00%
ATAI - COUR
45%
Loosely correlated
+1.75%
RGP - COUR
31%
Poorly correlated
+1.64%
EXPGY - COUR
31%
Poorly correlated
+0.86%
More